Sally C. Pipes

Commentary

Pending Government Drug Pricing Will Harm Seniors’ Care And Budgets

Any day now, the Biden administration will publish the prices it has set for ten drugs covered by Medicare’s Part D prescription drug benefit. These price controls will provide “meaningful financial relief for millions of people with Medicare,” administration officials say. Many seniors are about to see just how false that ...
Commentary

Harris is wrong about medical debt

Is Vice President Kamala Harris trying to rebrand as a centrist? She has recently disavowed her previous progressive positions on everything from border security to fracking to “Medicare for All.” But she and her running mate remain enthusiastic about socializing medical debt. In a recent statement, Harris claimed that “more than 100 million Americans struggle with medical ...
Commentary

Read the latest on pharmaceutical benefit managers

Legislation Urgently Needed to Rein In Pharmacy Benefit Mgrs.

The U.S. House Committee on Oversight and Accountability held a hearing last month with the CEOs of the nation’s three largest pharmacy benefit managers: CVS Caremark, Express Scripts, and OptumRx. The hearing coincided with a new report from the committee on the outsized role these prescription-drug middlemen play in determining what people pay for ...
Commentary

Joe Biden Leaves Behind A Disastrous Healthcare Legacy

President Joe Biden’s term will expire on January 20, 2025, when a new president will be inaugurated. He brought his decades-long political career to a close last month when he announced he would not seek re-election. Biden has thrown his support to his vice president, Kamala Harris, in this November’s election. ...
Commentary

Obamacare needs to police fraud

Are Obamacare’s exchanges hotbeds of fraud? New research suggests as much. An estimated 4 million to 5 million people have received fully subsidized health insurance by misrepresenting their income. That’s $20 billion lost to bogus enrollments this year. The problem stems from the original design of Obamacare – and the ...
Commentary

Vance Must Put America First on Healthcare

Ohio Sen. J.D. Vance has made quite a splash since arriving in Washington less than two years ago. He’s gone from the junior senator from Ohio and the 96th by seniority to the top of the Republican ticket as Donald Trump’s running mate. Vance has branded himself as an “America First” conservative. ...
Commentary

Kamala Harris’s healthcare record is rotten to the core

Democrats, including former President Barack Obama, have enthusiastically rallied around Vice President Kamala Harris as their presumptive presidential nominee. Voters will not be nearly as enthusiastic about her record on healthcare. Harris stands to President Joe Biden’s left on health policy. If elected, she would almost certainly drag the United States closer to a complete government ...
Commentary

Read about Biden's plan to extend health insurance to DACA

Biden’s Healthcare Amnesty Solves Nothing — and at a Staggering Cost

The Biden administration recently finalized a rule extending subsidized health coverage to approximately 100,000 people without health insurance who entered the United States illegally. These folks are part of the Deferred Action for Childhood Arrivals, or DACA, program — a group sometimes known as “dreamers.” The new rule effectively rewrites ...
Commentary

Fauci Has Only Himself to Blame for His COVID Legacy

“We have seen complete fabrications become some people’s accepted reality,” Dr. Anthony Fauci laments in his new memoir “On Call: A Doctor’s Journey in Public Service.” Surely the good doctor means to speak about his ideological foes, who have long decried the heavy-handed response to COVID-19 that Dr. Fauci symbolizes. But today, ...
Commentary

We’re Closer Than Ever To Beating Alzheimer’s. Price Controls Could Change That.

Earlier this month, the U.S. Food and Drug Administration approved donanemab, a novel treatment for Alzheimer’s disease that Eli Lilly will sell under the brand name Kisunla. The drug targets amyloid, a type of protein that builds up in the brains of people with the disease. It was shown to slow the ...
Commentary

Pending Government Drug Pricing Will Harm Seniors’ Care And Budgets

Any day now, the Biden administration will publish the prices it has set for ten drugs covered by Medicare’s Part D prescription drug benefit. These price controls will provide “meaningful financial relief for millions of people with Medicare,” administration officials say. Many seniors are about to see just how false that ...
Commentary

Harris is wrong about medical debt

Is Vice President Kamala Harris trying to rebrand as a centrist? She has recently disavowed her previous progressive positions on everything from border security to fracking to “Medicare for All.” But she and her running mate remain enthusiastic about socializing medical debt. In a recent statement, Harris claimed that “more than 100 million Americans struggle with medical ...
Commentary

Read the latest on pharmaceutical benefit managers

Legislation Urgently Needed to Rein In Pharmacy Benefit Mgrs.

The U.S. House Committee on Oversight and Accountability held a hearing last month with the CEOs of the nation’s three largest pharmacy benefit managers: CVS Caremark, Express Scripts, and OptumRx. The hearing coincided with a new report from the committee on the outsized role these prescription-drug middlemen play in determining what people pay for ...
Commentary

Joe Biden Leaves Behind A Disastrous Healthcare Legacy

President Joe Biden’s term will expire on January 20, 2025, when a new president will be inaugurated. He brought his decades-long political career to a close last month when he announced he would not seek re-election. Biden has thrown his support to his vice president, Kamala Harris, in this November’s election. ...
Commentary

Obamacare needs to police fraud

Are Obamacare’s exchanges hotbeds of fraud? New research suggests as much. An estimated 4 million to 5 million people have received fully subsidized health insurance by misrepresenting their income. That’s $20 billion lost to bogus enrollments this year. The problem stems from the original design of Obamacare – and the ...
Commentary

Vance Must Put America First on Healthcare

Ohio Sen. J.D. Vance has made quite a splash since arriving in Washington less than two years ago. He’s gone from the junior senator from Ohio and the 96th by seniority to the top of the Republican ticket as Donald Trump’s running mate. Vance has branded himself as an “America First” conservative. ...
Commentary

Kamala Harris’s healthcare record is rotten to the core

Democrats, including former President Barack Obama, have enthusiastically rallied around Vice President Kamala Harris as their presumptive presidential nominee. Voters will not be nearly as enthusiastic about her record on healthcare. Harris stands to President Joe Biden’s left on health policy. If elected, she would almost certainly drag the United States closer to a complete government ...
Commentary

Read about Biden's plan to extend health insurance to DACA

Biden’s Healthcare Amnesty Solves Nothing — and at a Staggering Cost

The Biden administration recently finalized a rule extending subsidized health coverage to approximately 100,000 people without health insurance who entered the United States illegally. These folks are part of the Deferred Action for Childhood Arrivals, or DACA, program — a group sometimes known as “dreamers.” The new rule effectively rewrites ...
Commentary

Fauci Has Only Himself to Blame for His COVID Legacy

“We have seen complete fabrications become some people’s accepted reality,” Dr. Anthony Fauci laments in his new memoir “On Call: A Doctor’s Journey in Public Service.” Surely the good doctor means to speak about his ideological foes, who have long decried the heavy-handed response to COVID-19 that Dr. Fauci symbolizes. But today, ...
Commentary

We’re Closer Than Ever To Beating Alzheimer’s. Price Controls Could Change That.

Earlier this month, the U.S. Food and Drug Administration approved donanemab, a novel treatment for Alzheimer’s disease that Eli Lilly will sell under the brand name Kisunla. The drug targets amyloid, a type of protein that builds up in the brains of people with the disease. It was shown to slow the ...
Scroll to Top